目的探讨马来酸罗格列酮(文迪雅)对2型糖尿病的临床疗效。
Objective To investigate clinical curative effect of rosiglitazone maleate (Avandia) in treating type 2 diabetes.
从1999年开始，马来酸罗格列酮和盐酸匹格列酮被批准使用。
Beginning in 1999, rosiglitazone maleate and pioglitazone hydrochloride were approved for use.
目的比较4个厂家马来酸罗格列酮胶囊的溶出度，为临床用药提供参考。
Objective To compare the dissolution of Rosiglitazone maleate capsules from 4 manufacturers, and provide Suggestions for clinical use.
方法采用正交试验设计法对片剂处方进行筛选与优化，确定最佳处方并制备马来酸罗格列酮胃漂浮缓释片剂；
Methods Orthogonal design was used to optimize the formulation of the tablets, and in vitro drug release was investigated with an UV method.
目的观察马来酸罗格列酮（商品名文迪雅）与胰岛素合用治疗2型糖尿病（T 2DM）的临床疗效和安全性。
OBJECTIVE To observe the clinical therapeutic effects and safety in the treatment of type 2 diabetes mellitus(T2DM) with Avandia and Insulin.
目的观察马来酸罗格列酮（商品名文迪雅）与胰岛素合用治疗2型糖尿病（T 2DM）的临床疗效和安全性。
OBJECTIVE To observe the clinical therapeutic effects and safety in the treatment of type 2 diabetes mellitus(T2DM) with Avandia and Insulin.
应用推荐